Ivarmacitinib
- Generic Name
- Ivarmacitinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H22N8O2S
- CAS Number
- 1445987-21-2
- Unique Ingredient Identifier
- K6K4B9Z5TV
- Background
Ivarmacitinib (SHR0302) is a selective inhibitor of Janus kinase 1 (JAK1) under investigation for the treatment of various immuno-inflammatory conditions. While ivarmactinib has yet to receive marketing authorization, as of February 2022 clinical trials are ongoing or completed evaluating its use in atopic dermatitis, ankylosing spondylitis, rheumatoid arthr...
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath